Journal of Clinical Endocrinology & Metabolism, Vol 78, 216-224, Copyright © 1994 by Endocrine Society

ARTICLES

Immunohistochemical localization of estradiol and progesterone receptors in human uterus throughout pregnancy: expression in endometrial blood vessels

M Perrot-Applanat, M Deng, H Fernandez, C Lelaidier, G Meduri and P Bouchard
Hormones et Reproduction, INSERM U135, Centre Hospitalo-Universitaire Kremlin-Bicetre, France.

Although progesterone and estrogens are essential to maintain human pregnancy after implantation, the localization of their specific receptors in different uterine cell types during pregnancy has not been investigated. We studied uteri (n = 40) obtained during the first 3 months of pregnancy (n = 21) and in late pregnancy (n = 9) as well as from women 5-14 weeks pregnant (n = 10) who had received the antiprogestagen RU 38486 (Roussel-UCLAF) to induce cervical dilation. Frozen tissues were processed for indirect immunocytochemical staining with specific monoclonal antibodies against estrogen receptors (ER; Abbott Laboratories) and progesterone receptors (PR; Li 417). Specific staining for steroid receptors was only detected in the nucleus. In the endometrium, PR staining remained fairly constant throughout pregnancy, whereas ER staining was initially weak and then undetectable. PR was widely expressed in stromal cells and in spiral arterial wall cells, whereas ER was expressed in scattered stromal cells and arterial cells. Both PR and ER were absent from glandular epithelium, contrasting with the secretory activity during the first trimester. Spiral arteries of the endometrium and myometrial smooth muscle cells showed intense PR and moderate ER staining in early pregnancy. The progesterone antagonist RU 38486 (mifepristone), given in early pregnancy at a dose of 200 mg, caused a marked increase in ER staining and a smaller increase in PR staining in stromal cells, whereas the glandular epithelium remained negative for both ER and PR (except for one and two specimens, respectively). We conclude the following. 1) Stromal cells retain PR despite the high progesterone levels during pregnancy, in keeping with the role of progesterone in stromal decidualization. The absence of PR from the secretory glandular epithelium suggests a paracrine link between decidualized stromal cells and epithelial cells. 2) Significant PR down-regulation by progesterone during pregnancy occurs only in epithelial cells of the endometrium. 3) In contrast, the absence or low level of ER staining in the various cell types of the endometrium during gestation concurs with the known effect (down- regulation) of steroid hormones on ER mRNA or protein levels. The increase in ER in human decidua after RU 38486 treatment indicates that the main cause of the low ER levels is progesterone secretion. 4) The intense PR staining in smooth muscle cells of spiral arteries during early pregnancy suggests that progesterone is essential for modulating blood flow during pregnancy.

This article has been cited by other articles:

				H. O. D. Critchley and P. T. K. Saunders Hormone Receptor Dynamics in a Receptive Human Endometrium Reproductive Sciences, February 1, 2009; 16(2): 191 - 199. [Abstract] [PDF]

				H. N. Jabbour, R. W. Kelly, H. M. Fraser, and H. O. D. Critchley Endocrine Regulation of Menstruation Endocr. Rev., February 1, 2006; 27(1): 17 - 46. [Abstract] [Full Text] [PDF]

				M A J Herve, G Meduri, F G Petit, T S Domet, G Lazennec, S Mourah, and M Perrot-Applanat Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus J. Endocrinol., January 1, 2006; 188(1): 91 - 99. [Abstract] [Full Text] [PDF]

				S Sukjumlong, A-M Dalin, L Sahlin, and E Persson Immunohistochemical studies on the progesterone receptor (PR) in the sow uterus during the oestrous cycle and in inseminated sows at oestrus and early pregnancy Reproduction, March 1, 2005; 129(3): 349 - 359. [Abstract] [Full Text] [PDF]

				M. Edlund, E. Andersson, and G. Fried Progesterone withdrawal causes endothelin release from cultured human uterine microvascular endothelial cells Hum. Reprod., June 1, 2004; 19(6): 1272 - 1280. [Abstract] [Full Text] [PDF]

				M. Winkler, B. Kemp, I. Clssen-Linke, D.-C. Fischer, S. Zaltinsi, J. Neulen, H. M. Beier, and W. Rath Estorgen Receptor {alpha} and Progesterone Receptor A and B Concentration and Localization the Lower Uterine Segment in Term Parturition Reproductive Sciences, July 1, 2002; 9(4): 226 - 232. [Abstract] [PDF]

				S. Hague, I.Z. MacKenzie, R. Bicknell, and M.C.P. Rees In-vivo angiogenesis and progestogens Hum. Reprod., March 1, 2002; 17(3): 786 - 793. [Abstract] [Full Text] [PDF]

				P. Bausero, M.-H. Ben-Mahdi, J.-P. Mazucatelli, C. Bloy, and M. Perrot-Applanat Vascular endothelial growth factor is modulated in vascular muscle cells by estradiol, tamoxifen, and hypoxia Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2033 - H2042. [Abstract] [Full Text] [PDF]

				C. Cudeville, F. Mondon, B. Robert, R. Rebourcet, T.-M. Mignot, C. Benassayag, and F. Ferré Evidence for Progesterone Receptors in the Human Fetoplacental Vascular Tree Biol Reprod, March 1, 2000; 62(3): 759 - 765. [Abstract] [Full Text]

				G. Meduri, P. Bausero, and M. Perrot-Applanat Expression of Vascular Endothelial Growth Factor Receptors in the Human Endometrium: Modulation During the Menstrual Cycle Biol Reprod, February 1, 2000; 62(2): 439 - 447. [Abstract] [Full Text]

				S. Freitas, G. Meduri, E. Le Nestour, P. Bausero, and M. Perrot-Applanat Expression of Metalloproteinases and Their Inhibitors in Blood Vesselsin Human Endometrium Biol Reprod, October 1, 1999; 61(4): 1070 - 1082. [Abstract] [Full Text]

				L. Zhang, M. C. Fishman, and P. L. Huang Estrogen Mediates the Protective Effects of Pregnancy and Chorionic Gonadotropin in a Mouse Model of Vascular Injury Arterioscler Thromb Vasc Biol, September 1, 1999; 19(9): 2059 - 2065. [Abstract] [Full Text] [PDF]

				C. Benassayag, M. J. Leroy, V. Rigourd, B. Robert, J. C. Honore, T. M. Mignot, M. C. Vacher-Lavenu, C. Chapron, and F. Ferre Estrogen receptors (ERalpha /ERbeta ) in normal and pathological growth of the human myometrium: pregnancy and leiomyoma Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1112 - E1118. [Abstract] [Full Text] [PDF]

				Z. Pengdi, L. Xiaoqun, L. Hongzhi, G. Zhao, C. Jie, X. Ruhua, L. Shizhu, W. Shangchun, and W. Jiedong The effect of a levonorgestrel-releasing intrauterine device on human endometrial oestrogen and progesterone receptors after one year of use Hum. Reprod., April 1, 1999; 14(4): 970 - 975. [Abstract] [Full Text] [PDF]

				A. Salmi, P. Heikkilä, S. Lintula, and E.-M. Rutanen Cellular Localization of c-Jun Messenger Ribonucleic Acid and Protein and Their Relation to the Proliferation Marker Ki-67 in the Human Endometrium J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1788 - 1796. [Abstract] [Full Text]

				E. Geimonen, E. Boylston, A. Royek, and J. Andersen Elevated Connexin-43 Expression in Term Human Myometrium Correlates with Elevated c-Jun Expression and Is Independent of Myometrial Estrogen Receptors J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1177 - 1185. [Abstract] [Full Text]

				S. Eissa, M. M. Mostafa, A. A. E. A. El-Gendy, and I. A. Senna Quantitative Immunological Detection of Total Estrogen Receptor (Cytosolic and Nuclear) in Term Decidua of Preeclampsia: a Preliminary Study Clin. Chem., February 1, 1997; 43(2): 405 - 406. [Full Text]

				M. Perrot-Applanat, K. Cohen-Solal, E. Milgrom, and M. Finet Progesterone Receptor Expression in Human Saphenous Veins Circulation, November 15, 1995; 92(10): 2975 - 2983. [Abstract] [Full Text]

				M. D. Mueller, J.-L. Vigne, A. Minchenko, D. I. Lebovic, D. C. Leitman, and R. N. Taylor Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta PNAS, September 26, 2000; 97(20): 10972 - 10977. [Abstract] [Full Text] [PDF]